Source: Virtual Congress 2020 – How do different treatment strategies translate into costs
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. Kuhlmann (Hanover, Germany), J. Graf Von Der Schulenburg (Hanover, Germany). Serotype dynamics in pneumococcal diseases and the performance of vaccination strategies for older adults in germany. 4808

Member's Comments

No comment yet.

Related content which might interest you: Impact of pneumococcal vaccination in children in the distribution of serotypes in bacteriemic pneumococcal pneumonia in adults Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis   Year: 2017 The remaining challenges of pneumococcal disease in adults Source: Eur Respir Rev 2012; 21: 57-65 Year: 2012 Additive preventive effect of influenza and pneumococcal vaccines in elderly persons Source: Eur Respir J 2004; 23: 363-368 Year: 2004 Pneumococcal polysaccharide vaccination in COPD patients - some problems with antibody-response Source: Eur Respir J 2002; 20: Suppl. 38, 472s Year: 2002 Protective effect of pneumococcal vaccine against death by pneumonia in elderly subjects Source: Eur Respir J 2005; 26: 1086-1091 Year: 2005 Clinical effectiveness of pneumococcal vaccination against nonbacteremic pneumonia in people over 50 years Source: Annual Congress 2008 - Community-acquired pneumonia: prognosis, complications and prevention Year: 2008 Influenza and pneumococcal vaccination in patients with COPD Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020 Factors affecting vaccination rates against influenza in adults with asthma Source: Virtual Congress 2020 – Epidemiology and understanding of airways diseases in primary care Year: 2020 Influenza vaccination in children with high-risk chronic diseases Source: Virtual Congress 2021 – Paediatric respiratory infections: chronic infection, vaccination and lung function Year: 2021 Impact of infant 13-valent pneumococcal conjugate vaccine on serotypes in adult pneumonia Source: Eur Respir J 2015; 45: 1632-1641 Year: 2015 Societal perspective and challenges of influenza and pneumococcal vaccination in patients at risk of respiratory complications Source: Annual Congress 2008 - Why vaccinate patients with chronic respiratory conditions? Today and tomorrow's perspectives Year: 2008 The development of pneumococcal infection in military populations Source: Eur Respir J 2004; 24: Suppl. 48, 364s Year: 2004 Clinical presentations and serotypes causing invasive pneumococcal disease in adults vaccinated with the 23-valent polysaccharide pneumococcal vaccine (PPV23) in Spain. The ODIN study (2010-2013) Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer Year: 2014 Effectiveness of a 23-valent pneumococcal polysaccharide vaccine and a 13-valent pneumococcal conjugate vaccine among the elderly with chronic respiratory diseases Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit Year: 2018 Perception and uptake of the influenza and pneumococcal vaccinations in patients with COPD Source: Annual Congress 2008 - Organisation of care and management of COPD Year: 2008 Vaccination rates against pneumococcal and influenza infection in hospitalized cardiologic and pneumologic patients need to be improved. Source: International Congress 2018 – Respiratory epidemiology:  from infectious diseases to lung cancer Year: 2018 Efficacy of vaccination to prevent pneumococcal infection in organized communities Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis   Year: 2017 Efficacy of influenza and pneumococcal vaccinations among patients with COPD Source: Annual Congress 2007 - Treatment of COPD Year: 2007 Impaired response to 13-valent pneumococcal conjugate vaccine (PCV13) in children with recurrent respiratory infections and chronic cough. Source: Virtual Congress 2021 – Paediatric respiratory infections: chronic infection, vaccination and lung function Year: 2021